168 related articles for article (PubMed ID: 23274950)
1. A novel stimuli-synchronized alloy-treated matrix for space-defined gastrointestinal delivery of mesalamine in the Large White pig model.
Bawa P; Choonara YE; du Toit LC; Kumar P; Ndesendo VM; Meyer LC; Pillay V
J Control Release; 2013 Mar; 166(3):234-45. PubMed ID: 23274950
[TBL] [Abstract][Full Text] [Related]
2. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations.
Das S; Ng KY; Ho PC
J Drug Target; 2011 Jul; 19(6):446-57. PubMed ID: 20684731
[TBL] [Abstract][Full Text] [Related]
3. Designing a biocompatible hydrogel for the delivery of mesalamine.
Neufeld L; Bianco-Peled H
Int J Pharm; 2015 Aug; 491(1-2):170-9. PubMed ID: 26116013
[TBL] [Abstract][Full Text] [Related]
4. Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.
Elbary AA; Aboelwafa AA; Al Sharabi IM
AAPS PharmSciTech; 2011 Dec; 12(4):1454-64. PubMed ID: 22038474
[TBL] [Abstract][Full Text] [Related]
5. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
[TBL] [Abstract][Full Text] [Related]
6. Selective drug delivery to the colon using pectin-coated pellets.
He W; Qing D; Cao DY; Fan LF; Xiang B
PDA J Pharm Sci Technol; 2008; 62(4):264-72. PubMed ID: 19174955
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release.
Das S; Chaudhury A; Ng KY
Int J Pharm; 2011 Mar; 406(1-2):11-20. PubMed ID: 21168477
[TBL] [Abstract][Full Text] [Related]
8. Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery: effect of swelling on triggering in vitro drug release.
Nunthanid J; Luangtana-anan M; Sriamornsak P; Limmatvapirat S; Huanbutta K; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2009 Feb; 71(2):356-61. PubMed ID: 18762255
[TBL] [Abstract][Full Text] [Related]
9. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
[TBL] [Abstract][Full Text] [Related]
10. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
Nguyen C; Christensen JM; Ayres JW
Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
[TBL] [Abstract][Full Text] [Related]
11. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
Newton AM; Lakshmanan P
Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
[TBL] [Abstract][Full Text] [Related]
12. Novel self-assembled mesalamine-sucralfate complexes: preparation, characterization, and formulation aspects.
Ispas-Szabo P; Friciu MM; Nguyen P; Dumoulin Y; Mateescu MA
Drug Dev Ind Pharm; 2016; 42(7):1183-93. PubMed ID: 26574144
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
Zambito Y; Di Colo G
J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
[TBL] [Abstract][Full Text] [Related]
14. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
16. Pectin-based microspheres for colon-specific delivery of vancomycin.
Bigucci F; Luppi B; Monaco L; Cerchiara T; Zecchi V
J Pharm Pharmacol; 2009 Jan; 61(1):41-6. PubMed ID: 19126295
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of the polyphosphates patched cellulose sulfate-chitosan hydrochloride microcapsules and as vehicles for sustained drug release.
Su T; Wu QX; Chen Y; Zhao J; Cheng XD; Chen J
Int J Pharm; 2019 Jan; 555():291-302. PubMed ID: 30471376
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro evaluation of pH, time-based and enzyme-degradable pellets for colonic drug delivery.
Fude C; Lei Y; Jie J; Hongze P; Wenhui L; Dongmei C
Drug Dev Ind Pharm; 2007 Sep; 33(9):999-1007. PubMed ID: 17891587
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of pectin-based colon-specific pulsatile capsule in vitro and in vivo.
Liu J; Zhang L; Jia Y; Hu W; Zhang J; Jiang H
Arch Pharm Res; 2012 Nov; 35(11):1927-34. PubMed ID: 23212634
[TBL] [Abstract][Full Text] [Related]
20. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.
Chuong MC; Christensen JM; Ayres JW
Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
